Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

MRI-Guided Ablation of Breast Cancer: Where Do We Stand Today? JOURNAL OF MAGNETIC RESONANCE IMAGING Postma, E. L., van Hillegersberg, R., Daniel, B. L., Merckel, L. G., Verkooijen, H. M., van den Bosch, M. A. 2011; 34 (2): 254-261

Abstract

The treatment of patients with localized breast cancer has changed considerably over the past few decades. The next challenge is to use image-guided minimally invasive tumor ablation techniques. The fact that MRI is the most accurate imaging modality for visualization and delineation of breast tumor margins in three dimensions and provides MRI-based temperature mapping, makes it particularly applicable for monitoring during minimally invasive ablation techniques. The overall result of the studies performed on MRI-guided minimally invasive tumor ablation studies are varying, with reported total tumor ablation rates ranging between 20% and 100%. Strict selection of patients, consensus on the treatment zone margin and optimization of MR-imaging, should make MRI-guided breast cancer tumor ablation a useful tool in clinical practice.

View details for DOI 10.1002/jmri.22599

View details for Web of Science ID 000293361300001

View details for PubMedID 21780220